Overview

A Phase 2 Study of the Safety and Efficacy of a Tofimilast in Adult Patients With Chronic Obstructive Pulmonary Disease

Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
This an initial proof of concept, phase to study to assess the safety and efficacy of tofimilast for the chronic maintenance treatment of adults with Chronic Obstructive Pulmonary Disease
Phase:
Phase 2
Details
Lead Sponsor:
Pfizer